top of page

Our Solution
We are fundamentally changing the Inflammatory Disorders space by unlocking the full potential of regulatory T cells (Tregs)
Bastion Therapeutics' HQ has officially closed. After a challenging and rewarding journey over the past 2 years, we’ve made the difficult decision to close our doors. Our lab has been emptied, and the team is unfortunately having to move on to new paths.
Our technology addresses the fundamental challenges that have limited previous generations of Treg therapies and unleashes the multi-functional capabilities of our GRIT™ cells
GRIT™ Platform For Disease-Specific Therapy
(Genetically Reconfigured & Improved Treg)
TARGET

REINFORCE

ENDURE

RESTORE

Enhancing Tregs To Restore Balance In Inflammatory Disorders
Our GRIT™ cells offer an innovative strategy to help suppress excessive immune responses. By engineering Tregs with our proprietary technology they have the potential to:
​
-
Target specific inflammatory sites with high specificity
​​
-
Recognise and bind to molecules specifically involved in inflammation
​​
-
Deliver regulatory signals and suppress inflammatory responses
​​
-
Reinforce Treg stability in harsh pro-inflammatory environments
​​
-
Endure to ensure persistence and longevity
​​
-
Repair and Regenerate damaged tissues


Our GRIT™ cells hold promise for treating inflammatory disorders and offer a targeted and precise therapy for restoring immune balance
Bastion Therapeutics' HQ has officially closed. After a challenging and rewarding journey over the past 2 years, we’ve made the difficult decision to close our doors. Our lab has been emptied, and the team is unfortunately having to move on to new paths.
Bastion Therapeutics' HQ has officially closed. After a challenging and rewarding journey over the past 2 years, we’ve made the difficult decision to close our doors. Our lab has been emptied, and the team is unfortunately having to move on to new paths.
bottom of page